Delcath Systems, Inc. (DCTH) Surpasses Q2 Earnings and Revenue Estimates

Company Performance - Delcath Systems, Inc. reported quarterly earnings of $0.07 per share, exceeding the Zacks Consensus Estimate of $0.02 per share, compared to a loss of $0.48 per share a year ago, representing an earnings surprise of +250.00% [1] - The company posted revenues of $24.16 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 9.30%, and showing significant growth from year-ago revenues of $7.77 million [2] - Over the last four quarters, Delcath Systems has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times [2] Stock Outlook - Delcath Systems shares have underperformed the market, losing about 12.6% since the beginning of the year, while the S&P 500 has gained 7.1% [3] - The current consensus EPS estimate for the coming quarter is $0.02 on revenues of $23.2 million, and for the current fiscal year, it is $0.33 on revenues of $94.8 million [7] - The estimate revisions trend for Delcath Systems was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market in the near future [6] Industry Context - The Medical - Instruments industry, to which Delcath Systems belongs, is currently in the bottom 41% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]